Glenmark Pharmaceuticals LimitedNSE: GLENMARK

Press Release Feb 27 2025

· Issued by Glenmark Pharmaceuticals Limited

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-feb-27-2025-4

Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated February 27, 2025, titled "Glenmark Pharmaceuticals Inc., USA launches Epinephrine Injection USP, 10 mg/10 mL (1 mg/mL) Multiple-Dose Vial".

View Attachment

6ix hasn’t read this filing yet.

Glenmark Pharmaceuticals Limited on 6ix

Earlier from Glenmark Pharmaceuticals

Later from Glenmark Pharmaceuticals

All Glenmark Pharmaceuticals news releases